Injecting nation: Achieving control of hepatitis C in Australia

Drug and Alcohol Review

Volumn 16, Issue 3, 1997, Pages 275-284

  Wodak, Alex ^a,b  

^a Drug and Alcohol Services   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Drug policy history; Hepatitis C control; Non injecting routes of administration

Indexed keywords

EID: 0031481581     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595239800187451     Document Type: Article

References (38)

1. Rankin J, Holst V, McKnight J, Moait S, Rae A. Committee of inquiry into the legal provision of heroin and other possible methods of diminishing crime associated with the supply and use of heroin. Sydney, 1981.
2. Uchtenhagen A, Dobler-Mikola A, Gutzwiller F. Medical Prescription of narcotics. Background and intermediate results of a Swiss National Project. Eur Addict Res 1996;2:201-7.
3. Bammer G. Report and recommendations of Stage 2, feasibility research into the controlled availability of opioids. National Centre for Epidemiology and Public Health and the Australian Institute of Criminology. Canberra: The Australian National University, 1995.
4. Manderson D. From Mr Sin to Mr Big. A history of Australian drug laws. Melbourne: Oxford University Press, 1993.
5. Premier's Drug Advisory Council. Drugs and our community. Melbourne: Joint Departmental Information Centre, 1996.
6. Stimson G. Drug injecting and HIV infection: new directions for social science research. Int J Addict 1992;27:147-63.
7. Parliamentary Joint Committee on the National Crime Authority. Drugs, crime and society. Canberra: Australian Government Publishing Service, 1989.
8. Australian Bureau of Criminal Intelligence. Australian illicit drug report 1995-96. Canberra, 1996.
9. Commission on Narcotic Drugs. Economic and social consequences of drug abuse and illicit drug trafficking: an interim report. Vienna: United Nations Economic and Social Council, 1995.
10. Westermeyer J. The pro-heroin effects of anti-opium laws in Asia. Arch Gen Psychiat 1976;33:1135-9.
11. Nadelmann E. Drug prohibition in the United States: costs, consequences and alternatives. Science 1989;245:939-47.
12. Wodak A, Owens R. Drug prohibition: a call for change. Sydney: UNSW Press, 1995.
13. Mann JM, Tarantola DJ, Netter TW. Aids in the world: the global AIDS policy coalition. Cambridge: Harvard University Press, 1992.
14. Riley KJ. Snow job? The war against international cocaine trafficking. New Brunswick Transaction Publishers, 1996.
15. Department of Health, Housing and Community Services. Statistics on drug abuse in Australia 1992. Canberra: Australian Government Publishing Service, 1992.
16. Crofts N, Jolly D, Kaldor J, van Beek I, Wodak A. The epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epi Comm Health, in press.
17. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, B human immunodeficiency and human t-lymphotropic viruses. Am J Pub Health 1996;86:655-61.
18. Moaven LD, Crofts N, Locarnini SA. Hepatitis C virus in Victorian injecting drug users in 1971 (letter). Med J Aust 1993;158:574.
19. Wodak A, Crofts N. Once more unto the breach: controlling hepatitis C in injecting drug users. Addiction 1996;91:181-4.
20. Wodak A, Crofts N. HIV revisited: preventing the spread of blood borne viruses among injecting drug users. Aust J Publ Health (Editorial) 1994;18:239-41.
21. MacDonald M, Wodak A, Ali R. HIV prevalence and risk behaviour in needle exchange attenders, Med J Aust. 1997;166:237-40.
22. Gerbeding JL. Drug therapy: management of occupational exposures to blood-borne viruses. N Engl J Med 1995;332:444-51.
23. Albertis A, Realdi G. Parentally-acquired non-A, non-B (type C) hepatitis. In: McIntyre N, Benhamou J-P, Bircher J, Rizzetto M, Rodes J, eds. Oxford textbook of clinical hepatology. Oxford: Oxford University Press, 1991, 605-17.
24. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long term mortality after transfusion associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-11.
25. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-66.
26. Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Publ Health 1995;85:1531-7.
27. Feachem RGA. Valuing the past... investing in the future. Evaluation of the National HIV/AIDS Strategy 1993-94 to 1995-96. Commonwealth Department of Human Services and Health. Canberra: Australian Government Publishing Service, 1995.
28. United States General Accounting Office. Confronting the drug problem: debate persists on enforcement and alternative approaches. Washington DC: US Government Report, 1993.
29. Griffiths P, Gossop M, Powis B, Strang J. Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction 1994;89:301-9.
30. Griffiths P, Gossop M, Strang J. Chasing the dragon: the development of heroin smoking in the United Kingdom. In Strang J, Gossop M, eds. Heroin addiction and drug policy. The British system. Oxford: Oxford University Press, 1994, 121-133.
31. Grund J-P, Blanken P. From chasing the dragon to chinezen. The diffusion of heroin smoking in the Netherlands. Instituut voor Verslavingsonderzoek (IVO). Rotterdam: Erasmus Universiteit, 1993.
32. Lurie P, Reingold AL, Bowser B, et al. The public health impact of needle exchange programs in the United States and abroad, vol. I. San Francisco: University of California, 1993.
33. National Research Council and Institute of Medicine. Preventing HIV transmission. The role of sterile needles and bleach. Washington DC: National Academy Press, 1995.
34. Weatherburn D, Lind B. Drug law enforcement policy and its impact on the heroin market. Sydney: New South Wales Bureau of Crime Statistics and Research, 1995.
35. Single E. The impact of marihuana decriminalisation: an update. J Publ Health Policy 1989;Winter:456-66.
36. Rydell CP, Everingham SS. Controlling cocaine. Supply versus demand programs. Santa Monica, CA: Drug Policy Research Centre, RAND, 1994.
37. Everingham SS, Rydell CP. Modelling the demand for cocaine. Santa Monica: RAND Drug Policy Research Center, 1994.
38. Edwards G, Anderson P, Babor TF et al. Alcohol policy and the public good. Oxford: Oxford University Press, 1994.